Silke Dehde
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.
Journal: Kidney international reports
Published: September 10, 2025
Functional characterization of podocyte-expressed THSD7A in experimental membranous nephropathy.
Journal: JCI insight
Published: July 25, 2025
Patient anti-PLA2R1 autoantibodies cause membranous nephropathy in human PLA2R1 transgenic mice.
Journal: Kidney international
Published: May 26, 2025
Non-invasive Diagnosis of Antinephrin-Associated Podocytopathy.
Journal: Kidney international reports
Published: April 15, 2025
Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions.
Journal: The Journal of clinical investigation
Published: January 17, 2025
Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy.
Journal: Kidney international
Published: November 21, 2024
Autoantibodies Targeting Nephrin in Podocytopathies.
Journal: The New England journal of medicine
Published: May 28, 2024
Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy.
Journal: Kidney international
Published: January 31, 2023
The classical pathway triggers pathogenic complement activation in membranous nephropathy.
Journal: Nature communications
Published: June 07, 2022
Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice.
Journal: Kidney international
Published: February 18, 2022
The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 27, 2017
Last Updated: 09/26/2026